ESP Equity Partners is a private equity firm based in Bedminster, New Jersey, established in 2000. The firm specializes in acquiring pharmaceutical and medical assets, focusing on targeted therapeutic areas. Through its buyout fund, ESP Equity Partners I, the firm aims to invest in sectors such as pharmaceuticals, biotechnology, and healthcare devices and supplies. This strategic focus allows ESP Equity Partners to identify and leverage opportunities within the healthcare industry, contributing to advancements in medical innovation.
Beijing Jiahui Center Tower B,1107 6 JiQingLi, Chaoyang District Beijing, 100020, China
Douglas Sheldon
Co - Founder and Managing Partner
3 past transactions
EKR Therapeutics
Series D in 2008
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products that primarily focus on oncology supportive care. EKR Therapeutics addresses various medical conditions, including oral mucositis, stomatitis, xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, and pain management, among others. Their products are designed to support the needs of patients in acute-care hospital settings, particularly cancer patients, by providing effective treatments for complications related to cancer and other conditions.
EKR Therapeutics
Series C in 2007
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products that primarily focus on oncology supportive care. EKR Therapeutics addresses various medical conditions, including oral mucositis, stomatitis, xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, and pain management, among others. Their products are designed to support the needs of patients in acute-care hospital settings, particularly cancer patients, by providing effective treatments for complications related to cancer and other conditions.
EKR Therapeutics
Series B in 2006
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products that primarily focus on oncology supportive care. EKR Therapeutics addresses various medical conditions, including oral mucositis, stomatitis, xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, and pain management, among others. Their products are designed to support the needs of patients in acute-care hospital settings, particularly cancer patients, by providing effective treatments for complications related to cancer and other conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.